Author:
Bussiere Jeanine L.,McCormick George C.,Green James D.
Reference90 articles.
1. Allison, A. C., and Byars, N. E., 1992, Immunological adjuvants and their mode of action, in: Vaccines: New Approaches to Immunological Problems (R. W. Ellis, ed.), Butterworths-Heinemann, London, pp. 431–449.
2. Aprile, M. A., and Wardlaw, A. C., 1966, Aluminium compounds as adjuvants for vaccines and toxoids in man: A review, Can. J. Public Health 57(8):343–360.
3. Audibert, F. M., and Lise, L. D., 1993, Adjuvants: Current status, clinical perspectives and future prospects, Immunol. Today 14(6):281–284.
4. Boldogh, I., Abubakar, S., Fons, M. P., Deng, C. Z., and Albrecht, T., 1991, Activation of cellular oncogenes by clinical isolates and laboratory strains of human cytomegalovirus, J. Med. Virol. 34:241–247.
5. Bollinger, R. C., Quinn, T. C., Liu, A. Y., Stanhope, P. E., Hammond, S. A., Viveen, R., Clements, M. L., and Siliciano, R. F., 1993, Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: Effects on viral replication, AIDS Res. Hum. Retroviruses 9(11): 1067–1077.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献